Parkinson's Disease INSIGHTS

Parkinson's Disease, Your Appendix, and the Microbiome

photo from Parkinson's Disease, Your Appendix, and the Microbiome

Parkinson's disease (PD) affects 1 million people in the U.S. annually and there is no known cure. Can connections between the gut microbiome, the appendix, and the pathology of PD provide fresh therapeutic options? State of Parkinson's Disease Treatment Primary treatments and research areas for PD historically revolved around drugs that increase the levels of dopamine in the synaptic space (Levodopa, Lodosyn, Duopa), medications that act as...  Read More

Parkinson's Disease Model with Endogenous LRRK2 Regulation

photo from Parkinson's Disease Model with Endogenous LRRK2 Regulation

No single Parkinson's Disease (PD) model fully reproduces the complexity of the disease in humans. Developing an assortment of PD models has been essential for furthering our understanding of, and the development of potential treatments for, the disease. Adding to the arsenal of PD rodent models, in conjunction with The Michael J. Fox Foundation (MJFF) for Parkinson's Research, a mouse model carrying targeted replacement human LRRK2 G2019S...  Read More

Accelerating Parkinson's Disease Research Through Strategic Partnerships

photo from Accelerating Parkinson's Disease Research Through Strategic Partnerships

The Michael J. Fox Foundation (MJFF), established in 2000, is dedicated to finding a cure for Parkinson's disease (PD) by supporting research agendas toward development of improved therapies for Parkinson's disease patients. Unlike many private research funding institutions that rely on external scientific advisors and boards for how to allocate donor-raised research dollars, the MJFF has an in-house team of trained scientists and project managers that oversee...  Read More

Fecal Microbiota Study Links Parkinson's Disease and the Microbiome

photo from Fecal Microbiota Study Links Parkinson's Disease and the Microbiome

In a recent Cell publication, a team led by Timothy Sampson and Sarkis Mazmanian of Caltech showed that gut microbiota can promote inflammation of neurons and motor deficits in a human α-synuclein mouse model of Parkinson's disease. Connecting Parkinson's Disease and the Microbiome Emerging data suggest bidirectional communication between the gut and the brain in anxiety, depression, nociception, and autism spectrum disorder1,5,6. Much has been postulated over...  Read More